This new study suggests that the delayed detection of breast cancer due to the challenges in recognizing symptoms, such as lumps, may contribute to the development of symptoms similar to those observed in long COVID patients. The connection between the delayed diagnosis of breast cancer and long COVID symptoms underscores the importance of early detection and timely medical intervention in the management of various health conditions.
A recent study has proposed that reduced levels of serotonin in the body could potentially play a role in the onset and persistence of “long COVID” symptoms. Researchers suggest that, even after the acute COVID symptoms have resolved, remnants of the virus may linger in the gastrointestinal tract, a primary site for serotonin production. In this location, the virus is believed to decrease the levels of this crucial chemical. Consequently, the low levels of serotonin might contribute to some of the frequently reported long COVID symptoms, including cognitive difficulties and memory problems, according to the findings of this study. This research sheds light on a potential link between the virus’s presence in the gut and the long-term health effects experienced by some COVID-19 survivors.
For the study, published Monday in the journal Cell, researchers at Penn Medicine conducted an analysis using questionnaire surveys and medical chart reviews of 1,540 patients hospitalized with long COVID.
Patients reported symptoms including fatigue, cognitive difficulties, headaches, anxiety, loss of endurance, problems with sleep, and memory loss – all typically associated with long COVID diagnosis.
In addition to exploring the role of serotonin in long COVID, the study delved into blood samples from various groups. These samples included 58 long COVID patients, 30 individuals who had fully recovered from COVID, and 60 people currently experiencing an active COVID infection. This new study suggests
By comparing these samples, the researchers aimed to gain insights into the differences in markers, including serotonin levels, among these different groups of individuals. This comprehensive approach allowed for a more thorough examination of the factors contributing to the development of long COVID symptoms.